首页> 美国卫生研究院文献>Clinical and Diagnostic Laboratory Immunology >Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity

【2h】

Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity

机译：单磷酰脂质A通过增强体液和细胞免疫力来提高土拉弗朗西斯菌拉维丝-钙纳米颗粒亚单位疫苗对抗土拉弗朗西斯科S4 S4攻击的功效。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Clinical and Diagnostic Laboratory Immunology
作者
Katharina Richard; Barbara J. Mann; Aiping Qin; Eileen M. Barry; Robert K. Ernst; Stefanie N. Vogel;
展开▼
作者单位

展开▼
年(卷),期 2017(24),3
年度 2017
页码 e00574-16
总页数 15
原文格式 PDF
正文语种
中图分类免疫学;
关键词

相似文献

外文文献
中文文献
专利

1. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity [J] . Katharina Richard, Barbara J. Mann, Aiping Qin, Clinical and vaccine immunology: CVI . 2017,第3期

机译：单磷酰脂质A通过增强体液和细胞免疫能力，提高了土拉弗朗西斯菌拉维丝-钙纳米颗粒亚单位疫苗对抗土拉弗朗西斯Schu S4攻击的功效。
2. Novel Catanionic Surfactant Vesicle Vaccines Protect against Francisella tularensis LVS and Confer Significant Partial Protection against F. tularensis Schu S4 Strain [J] . Katharina Richard, Barbara J. Mann, Lenea Stocker, Clinical and vaccine immunology: CVI . 2014,第2期

机译：新型阳离子表面活性剂囊泡疫苗可预防土拉弗朗西斯菌LVS并提供对F. tularensis Schu S4菌株的重要部分保护
3. iTRAQ quantitative analysis of Francisella tularensis ssp. holarctica live vaccine strain and Francisella tularensis ssp. tularensis SCHU S4 response to different temperatures and stationary phases of growth [J] . Proteomics . 2009,第10期

机译：图拉弗朗西斯菌的iTRAQ定量分析holarctica活疫苗菌株和弗朗西斯菌tularensis ssp。 tularensis SCHU S4对不同温度和生长稳定期的响应
4. Single dose polyanhydride nanoparticle-based vaccine safely induces both cellular and humoral immunity [C] . Y. Phanse, L.K. Petersen, S. Haughney, Society for Biomaterials annual meeting and exposition . 2013

机译：单剂量基于聚酸酐纳米颗粒的疫苗可安全诱导细胞和体液免疫
5. The Role of Complement C3 as a Trigger for Human Macrophage Death During Infection with Francisella tularensis Strain SCHU S4 [D] . Brock, Susan R. 2018

机译：补体C3感染土拉弗朗西斯菌SCHU S4期间触发人类巨噬细胞死亡的作用。
6. Novel Catanionic Surfactant Vesicle Vaccines Protect against Francisella tularensis LVS and Confer Significant Partial Protection against F. tularensis Schu S4 Strain [O] . Katharina Richard, Barbara J. Mann, Lenea Stocker, 2014

机译：新型阳离子表面活性剂囊泡疫苗可预防土拉弗朗西斯菌LVS并提供对F. tularensis Schu S4菌株的重要部分保护
7. Characterization of Inner and Outer Membrane Proteins from Francisella tularensis Strains LVS and Schu S4 and Identification of Potential Subunit Vaccine Candidates [O] . Deborah M. B. Post, Bram Slutter, Birgit Schilling, 2017

机译：土拉弗朗西斯菌LVs和schu s4内外膜蛋白的表征及潜在亚单位疫苗候选物的鉴定

Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity

著录项

相似文献

相关主题

期刊订阅